Through advancements in science, medicine, and genomics, we aim
to improve the lives of patients who suffer from cancer and other
debilitating diseases.

Diverse Biotech is a biopharmaceutical research company, focused on new medical discoveries and the development of new molecules for the treatment of disease. Commercialization path of these new discoveries include;

1. Our continuous commitment to follow the FDA New Drug Application for commercialization.
2. Identifying synergies with bio-pharma companies, for the ongoing development of new assets in oncology, dermatology and inflammatory therapeutic indications.
3. Creating collaborations around licensing opportunities